| Product Code: ETC7765777 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Jordan Oncology Molecular Diagnostic Market Overview |
3.1 Jordan Country Macro Economic Indicators |
3.2 Jordan Oncology Molecular Diagnostic Market Revenues & Volume, 2021 & 2031F |
3.3 Jordan Oncology Molecular Diagnostic Market - Industry Life Cycle |
3.4 Jordan Oncology Molecular Diagnostic Market - Porter's Five Forces |
3.5 Jordan Oncology Molecular Diagnostic Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Jordan Oncology Molecular Diagnostic Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.7 Jordan Oncology Molecular Diagnostic Market Revenues & Volume Share, By Test Location, 2021 & 2031F |
3.8 Jordan Oncology Molecular Diagnostic Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.9 Jordan Oncology Molecular Diagnostic Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Jordan Oncology Molecular Diagnostic Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer cases in Jordan |
4.2.2 Growing demand for personalized medicine and targeted therapy |
4.2.3 Advancements in molecular diagnostic technologies |
4.3 Market Restraints |
4.3.1 Limited awareness and access to molecular diagnostic tests in certain regions of Jordan |
4.3.2 High costs associated with molecular diagnostic testing |
4.3.3 Regulatory challenges and reimbursement issues |
5 Jordan Oncology Molecular Diagnostic Market Trends |
6 Jordan Oncology Molecular Diagnostic Market, By Types |
6.1 Jordan Oncology Molecular Diagnostic Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Jordan Oncology Molecular Diagnostic Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Jordan Oncology Molecular Diagnostic Market Revenues & Volume, By Breast Cancer, 2021- 2031F |
6.1.4 Jordan Oncology Molecular Diagnostic Market Revenues & Volume, By Prostate Cancer, 2021- 2031F |
6.1.5 Jordan Oncology Molecular Diagnostic Market Revenues & Volume, By Colorectal Cancer, 2021- 2031F |
6.1.6 Jordan Oncology Molecular Diagnostic Market Revenues & Volume, By Cervical Cancer, 2021- 2031F |
6.1.7 Jordan Oncology Molecular Diagnostic Market Revenues & Volume, By Liver Cancer, 2021- 2031F |
6.1.8 Jordan Oncology Molecular Diagnostic Market Revenues & Volume, By Lung Cancer, 2021- 2031F |
6.1.9 Jordan Oncology Molecular Diagnostic Market Revenues & Volume, By Others, 2021- 2031F |
6.1.10 Jordan Oncology Molecular Diagnostic Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Jordan Oncology Molecular Diagnostic Market, By Product |
6.2.1 Overview and Analysis |
6.2.2 Jordan Oncology Molecular Diagnostic Market Revenues & Volume, By Instruments, 2021- 2031F |
6.2.3 Jordan Oncology Molecular Diagnostic Market Revenues & Volume, By Reagents, 2021- 2031F |
6.2.4 Jordan Oncology Molecular Diagnostic Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Jordan Oncology Molecular Diagnostic Market, By Test Location |
6.3.1 Overview and Analysis |
6.3.2 Jordan Oncology Molecular Diagnostic Market Revenues & Volume, By Clinics, 2021- 2031F |
6.3.3 Jordan Oncology Molecular Diagnostic Market Revenues & Volume, By Other Establishments, 2021- 2031F |
6.3.4 Jordan Oncology Molecular Diagnostic Market Revenues & Volume, By Point of Care, 2021- 2031F |
6.4 Jordan Oncology Molecular Diagnostic Market, By Technology |
6.4.1 Overview and Analysis |
6.4.2 Jordan Oncology Molecular Diagnostic Market Revenues & Volume, By PCR, 2021- 2031F |
6.4.3 Jordan Oncology Molecular Diagnostic Market Revenues & Volume, By Multiplex, 2021- 2031F |
6.4.4 Jordan Oncology Molecular Diagnostic Market Revenues & Volume, By Others, 2021- 2031F |
6.4.5 Jordan Oncology Molecular Diagnostic Market Revenues & Volume, By In Situ Hybridization, 2021- 2031F |
6.4.6 Jordan Oncology Molecular Diagnostic Market Revenues & Volume, By Isothermal Nucleic Acid Amplification Technology (INAAT), 2021- 2031F |
6.4.7 Jordan Oncology Molecular Diagnostic Market Revenues & Volume, By Chips and Microarrays, 2021- 2031F |
6.4.8 Jordan Oncology Molecular Diagnostic Market Revenues & Volume, By Others, 2021- 2031F |
6.4.9 Jordan Oncology Molecular Diagnostic Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Jordan Oncology Molecular Diagnostic Market, By End User |
6.5.1 Overview and Analysis |
6.5.2 Jordan Oncology Molecular Diagnostic Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 Jordan Oncology Molecular Diagnostic Market Revenues & Volume, By Diagnostic Centers, 2021- 2031F |
7 Jordan Oncology Molecular Diagnostic Market Import-Export Trade Statistics |
7.1 Jordan Oncology Molecular Diagnostic Market Export to Major Countries |
7.2 Jordan Oncology Molecular Diagnostic Market Imports from Major Countries |
8 Jordan Oncology Molecular Diagnostic Market Key Performance Indicators |
8.1 Adoption rate of molecular diagnostic tests by healthcare providers in Jordan |
8.2 Number of collaborations between diagnostic companies and research institutions in Jordan |
8.3 Percentage of cancer patients in Jordan undergoing molecular diagnostic testing |
8.4 Rate of introduction of new molecular diagnostic technologies in the Jordanian market |
9 Jordan Oncology Molecular Diagnostic Market - Opportunity Assessment |
9.1 Jordan Oncology Molecular Diagnostic Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Jordan Oncology Molecular Diagnostic Market Opportunity Assessment, By Product, 2021 & 2031F |
9.3 Jordan Oncology Molecular Diagnostic Market Opportunity Assessment, By Test Location, 2021 & 2031F |
9.4 Jordan Oncology Molecular Diagnostic Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.5 Jordan Oncology Molecular Diagnostic Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Jordan Oncology Molecular Diagnostic Market - Competitive Landscape |
10.1 Jordan Oncology Molecular Diagnostic Market Revenue Share, By Companies, 2024 |
10.2 Jordan Oncology Molecular Diagnostic Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here